New research shows positive experiences may boost the brain’s energy transformation, possibly building resilience against brain disorders in later life.
People with a history of cognitively stimulating occupations during their 30s, 40s, 50s, and 60s had a lower risk of mild cognitive impairment and dementia after age 70.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
This July, Columbia neurologist Mitch Elkind will become president of the American Heart Association, only the second time a neurologist has led the organization.
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
The source of essential tremor—involuntary, rhythmic trembling—has been elusive, but a new study points to abnormal electrical activity in the base of the brain.
Researchers had high hopes for Alzheimer’s drugs that clear amyloid from the brain, but none of the drugs have slowed the disease. Columbia’s Scott Small says he has new reasons to be optimistic.
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.
Only select neurons die during Parkinson’s disease. Columbia researchers are looking for clues in immune cells to find out what makes these brain cells so vulnerable.
With several targeted Parkinson’s disease drugs entering clinical trials, a new genetic testing and counseling program may help identify patients who qualify for enrollment.